首页|Hospital Israelita Albert Einstein Reports Findings in Colon Cancer (Oncologic o utcomes for robotic versus laparoscopic colectomy for colon cancer: an ACS-NSQIP analysis)
Hospital Israelita Albert Einstein Reports Findings in Colon Cancer (Oncologic o utcomes for robotic versus laparoscopic colectomy for colon cancer: an ACS-NSQIP analysis)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Oncology - Colon Cance r is the subject of a report. According to news reporting originating in Sao Pau lo, Brazil, by NewsRx journalists, research stated, "Robotic colectomy has been associated with comparable or improved short-term morbidity and mortality when c ompared to laparoscopic colectomy, including shorter length of stay. In this stu dy, we sought to understand oncologic advantages for robotic as compared to lapa roscopic colectomy in colon cancer." The news reporters obtained a quote from the research from Hospital Israelita Al bert Einstein, "We analyzed the American College of Surgeons National Surgical Q uality Improvement Program (NSQIP) participant user files for All elective colon cancer cases from 1/2016 through 12/2021 performed with minimAlly invasive surg ical techniques (robotic and laparoscopic). We calculated relative risks (RR) th rough Poisson Regression models and treatment effect coefficients by propensity- score match, after adjusting for age, BMI, ASA scores, mechanical and antibiotic bowel preparation, emergency surgery, race, gender, smoking status, hypertensio n and diabetes mellitus. Analyzed outcomes included rate of chemotherapy initiat ion within 90 days of surgery, number of harvested lymph nodes, any occurrence o f intraoperative or postoperative blood transfusion, and the need for ostomy. Du ring the study period, 44,745 patients underwent minimAlly invasive colectomy fo r colon cancer; 39,614 in the laparoscopic cohort and 7,831 in the robotic cohor t. After adjusting for confounders, robotic colectomy was associated with a sign ificant increase in the likelihood for initating chemotherapy within 90 days (RR 1.98, 95% CI {1.86-2.10} , p<0.001). The robotic-treated patients had a significantly more lymph nodes harve sted, a significant decrease in the need for intraperative or postoperative bloo d transfusion (RR 0.64, 95% CI {0.57-0.71} , p<0.001) and a significant reduction in the need for ost omy formation (RR 0.26, 95% CI {0.22-0.30} , p<0.001). As a retrospective and non-randomized study, r esidual bias and confouding variables are likely to exist. The study is also sub ject to coding incompleteness and inaccuracies. We also do not have additional c ontext on potential factors that might influence time to chemotherapy. In additi on, there is no information on surgeon or hospital volume, which can be associat ed with outcomes. Robotic colectomy for colon cancer was associated with signifi cant improvement in the rate of chemotherapy initiation within 90 days, a signif icant reduction in need for blood transfusions, and a lower likelihood of receiv ing an ostomy when compared to laparoscopic colectomy procedures."
Sao PauloBrazilSouth AmericaBiolog ical TherapyCancerChemotherapyColectomyColon CancerDigestive System Su rgical ProceduresDrugs and TherapiesEmerging TechnologiesHealth and Medici neMachine LearningOncologyOperative Surgical ProceduresOstomyRoboticsRobotsSurgery
NETL
NSTL
